vs
汉瑞祥（HSIC）与Masco（MAS）财务数据对比。点击上方公司名可切换其他公司
汉瑞祥的季度营收约是Masco的1.8倍（$3.4B vs $1.9B），Masco净利率更高（11.9% vs 2.9%，领先8.9%），汉瑞祥同比增速更快（7.7% vs 6.5%），过去两年汉瑞祥的营收复合增速更高（4.1% vs -4.2%）
汉瑞祥（Henry Schein, Inc.）是美国的医疗保健产品及服务分销商，业务覆盖全球33个国家和地区，是全球面向诊所类牙科及医疗从业者的最大医疗解决方案供应商。公司连续14年入选Ethisphere评选的「全球最具道德企业」榜单，2025年再次登榜。
美国家居建材企业Masco主营家装及新建住宅市场相关产品，旗下拥有20余家子公司，在全球运营近80座生产工厂，其中美国本土近60座，海外地区超20座。公司1969年于纽交所挂牌上市，后实现快速增长，成功跻身美国财富500强榜单。
HSIC vs MAS — 直观对比
营收规模更大
HSIC
是对方的1.8倍
$1.9B
营收增速更快
HSIC
高出1.2%
6.5%
净利率更高
MAS
高出8.9%
2.9%
两年增速更快
HSIC
近两年复合增速
-4.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.4B | $1.9B |
| 净利润 | $101.0M | $228.0M |
| 毛利率 | 30.9% | 35.8% |
| 营业利润率 | 4.7% | 16.5% |
| 净利率 | 2.9% | 11.9% |
| 营收同比 | 7.7% | 6.5% |
| 净利润同比 | 7.4% | 14.5% |
| 每股收益（稀释后） | $0.85 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HSICMAS
| Q1 26 | — | $1.9B | ||
| Q4 25 | $3.4B | $1.8B | ||
| Q3 25 | $3.3B | $1.9B | ||
| Q2 25 | $3.2B | $2.1B | ||
| Q1 25 | $3.2B | $1.8B | ||
| Q4 24 | $3.2B | $1.8B | ||
| Q3 24 | $3.2B | $2.0B | ||
| Q2 24 | $3.1B | $2.1B |
净利润HSICMAS
| Q1 26 | — | $228.0M | ||
| Q4 25 | $101.0M | $165.0M | ||
| Q3 25 | $101.0M | $189.0M | ||
| Q2 25 | $86.0M | $270.0M | ||
| Q1 25 | $110.0M | $186.0M | ||
| Q4 24 | $94.0M | $182.0M | ||
| Q3 24 | $99.0M | $167.0M | ||
| Q2 24 | $104.0M | $258.0M |
毛利率HSICMAS
| Q1 26 | — | 35.8% | ||
| Q4 25 | 30.9% | 33.9% | ||
| Q3 25 | 30.7% | 34.2% | ||
| Q2 25 | 31.4% | 37.6% | ||
| Q1 25 | 31.6% | 35.8% | ||
| Q4 24 | 31.1% | 34.8% | ||
| Q3 24 | 31.3% | 36.6% | ||
| Q2 24 | 32.5% | 37.5% |
营业利润率HSICMAS
| Q1 26 | — | 16.5% | ||
| Q4 25 | 4.7% | 13.8% | ||
| Q3 25 | 4.9% | 15.8% | ||
| Q2 25 | 4.7% | 20.1% | ||
| Q1 25 | 5.5% | 15.9% | ||
| Q4 24 | 4.9% | 15.9% | ||
| Q3 24 | 4.9% | 18.0% | ||
| Q2 24 | 5.1% | 19.0% |
净利率HSICMAS
| Q1 26 | — | 11.9% | ||
| Q4 25 | 2.9% | 9.2% | ||
| Q3 25 | 3.0% | 9.9% | ||
| Q2 25 | 2.7% | 13.2% | ||
| Q1 25 | 3.5% | 10.3% | ||
| Q4 24 | 2.9% | 10.0% | ||
| Q3 24 | 3.1% | 8.4% | ||
| Q2 24 | 3.3% | 12.3% |
每股收益（稀释后）HSICMAS
| Q1 26 | — | — | ||
| Q4 25 | $0.85 | $0.81 | ||
| Q3 25 | $0.84 | $0.90 | ||
| Q2 25 | $0.70 | $1.28 | ||
| Q1 25 | $0.88 | $0.87 | ||
| Q4 24 | $0.75 | $0.85 | ||
| Q3 24 | $0.78 | $0.77 | ||
| Q2 24 | $0.80 | $1.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $156.0M | — |
| 总债务越低越好 | $2.3B | $2.9B |
| 股东权益账面价值 | $3.2B | $27.0M |
| 总资产 | $11.2B | $5.2B |
| 负债/权益比越低杠杆越低 | 0.71× | 109.07× |
8季度趋势，按日历期对齐
现金及短期投资HSICMAS
| Q1 26 | — | — | ||
| Q4 25 | $156.0M | $647.0M | ||
| Q3 25 | $136.0M | $559.0M | ||
| Q2 25 | $145.0M | $390.0M | ||
| Q1 25 | $127.0M | $377.0M | ||
| Q4 24 | $122.0M | $634.0M | ||
| Q3 24 | $126.0M | $646.0M | ||
| Q2 24 | $138.0M | $398.0M |
总债务HSICMAS
| Q1 26 | — | $2.9B | ||
| Q4 25 | $2.3B | $2.9B | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $1.8B | $2.9B | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.9B | — |
股东权益HSICMAS
| Q1 26 | — | $27.0M | ||
| Q4 25 | $3.2B | $-185.0M | ||
| Q3 25 | $3.4B | $-78.0M | ||
| Q2 25 | $3.4B | $-84.0M | ||
| Q1 25 | $3.3B | $-254.0M | ||
| Q4 24 | $3.4B | $-279.0M | ||
| Q3 24 | $3.5B | $-88.0M | ||
| Q2 24 | $3.5B | $-26.0M |
总资产HSICMAS
| Q1 26 | — | $5.2B | ||
| Q4 25 | $11.2B | $5.2B | ||
| Q3 25 | $11.1B | $5.3B | ||
| Q2 25 | $10.9B | $5.3B | ||
| Q1 25 | $10.5B | $5.1B | ||
| Q4 24 | $10.2B | $5.0B | ||
| Q3 24 | $10.6B | $5.3B | ||
| Q2 24 | $10.3B | $5.4B |
负债/权益比HSICMAS
| Q1 26 | — | 109.07× | ||
| Q4 25 | 0.71× | — | ||
| Q3 25 | 0.64× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.59× | — | ||
| Q4 24 | 0.54× | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | 0.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $381.0M | — |
| 自由现金流经营现金流 - 资本支出 | $338.0M | — |
| 自由现金流率自由现金流/营收 | 9.8% | — |
| 资本支出强度资本支出/营收 | 1.3% | 1.8% |
| 现金转化率经营现金流/净利润 | 3.77× | — |
| 过去12个月自由现金流最近4个季度 | $573.0M | — |
8季度趋势，按日历期对齐
经营现金流HSICMAS
| Q1 26 | — | — | ||
| Q4 25 | $381.0M | $418.0M | ||
| Q3 25 | $174.0M | $456.0M | ||
| Q2 25 | $120.0M | $306.0M | ||
| Q1 25 | $37.0M | $-158.0M | ||
| Q4 24 | $204.0M | $407.0M | ||
| Q3 24 | $151.0M | $416.0M | ||
| Q2 24 | $296.0M | $346.0M |
自由现金流HSICMAS
| Q1 26 | — | — | ||
| Q4 25 | $338.0M | $371.0M | ||
| Q3 25 | $141.0M | $415.0M | ||
| Q2 25 | $88.0M | $270.0M | ||
| Q1 25 | $6.0M | $-190.0M | ||
| Q4 24 | $168.0M | $351.0M | ||
| Q3 24 | $117.0M | $378.0M | ||
| Q2 24 | $259.0M | $303.0M |
自由现金流率HSICMAS
| Q1 26 | — | — | ||
| Q4 25 | 9.8% | 20.7% | ||
| Q3 25 | 4.2% | 21.6% | ||
| Q2 25 | 2.7% | 13.2% | ||
| Q1 25 | 0.2% | -10.5% | ||
| Q4 24 | 5.3% | 19.2% | ||
| Q3 24 | 3.7% | 19.1% | ||
| Q2 24 | 8.3% | 14.5% |
资本支出强度HSICMAS
| Q1 26 | — | 1.8% | ||
| Q4 25 | 1.3% | 2.6% | ||
| Q3 25 | 1.0% | 2.1% | ||
| Q2 25 | 1.0% | 1.8% | ||
| Q1 25 | 1.0% | 1.8% | ||
| Q4 24 | 1.1% | 3.1% | ||
| Q3 24 | 1.1% | 1.9% | ||
| Q2 24 | 1.2% | 2.1% |
现金转化率HSICMAS
| Q1 26 | — | — | ||
| Q4 25 | 3.77× | 2.53× | ||
| Q3 25 | 1.72× | 2.41× | ||
| Q2 25 | 1.40× | 1.13× | ||
| Q1 25 | 0.34× | -0.85× | ||
| Q4 24 | 2.17× | 2.24× | ||
| Q3 24 | 1.53× | 2.49× | ||
| Q2 24 | 2.85× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HSIC
| Global Dental Merchandise | $1.2B | 35% |
| Global Medical | $1.1B | 31% |
| Global Dental Equipment | $536.0M | 16% |
| Global Specialty Products | $422.0M | 12% |
| Global Technology | $173.0M | 5% |
| Global Value Added Services | $64.0M | 2% |
| Equity Method Investee | $14.0M | 0% |
MAS
暂无分部数据
